ES3061451T3 - Hybrid amide derivatives of amphotericin b - Google Patents

Hybrid amide derivatives of amphotericin b

Info

Publication number
ES3061451T3
ES3061451T3 ES21856507T ES21856507T ES3061451T3 ES 3061451 T3 ES3061451 T3 ES 3061451T3 ES 21856507 T ES21856507 T ES 21856507T ES 21856507 T ES21856507 T ES 21856507T ES 3061451 T3 ES3061451 T3 ES 3061451T3
Authority
ES
Spain
Prior art keywords
amphotericin
amide derivatives
salts
hybrid amide
hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21856507T
Other languages
English (en)
Spanish (es)
Inventor
Martin Burke
Arun Maji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois at Urbana Champaign
University of Illinois System
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois System filed Critical University of Illinois at Urbana Champaign
Application granted granted Critical
Publication of ES3061451T3 publication Critical patent/ES3061451T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES21856507T 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b Active ES3061451T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063063655P 2020-08-10 2020-08-10
US202163175771P 2021-04-16 2021-04-16
PCT/US2021/045205 WO2022035752A1 (en) 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b

Publications (1)

Publication Number Publication Date
ES3061451T3 true ES3061451T3 (en) 2026-04-01

Family

ID=80247344

Family Applications (1)

Application Number Title Priority Date Filing Date
ES21856507T Active ES3061451T3 (en) 2020-08-10 2021-08-09 Hybrid amide derivatives of amphotericin b

Country Status (12)

Country Link
US (1) US20230357303A1 (https=)
EP (2) EP4696379A3 (https=)
JP (1) JP7656359B2 (https=)
KR (1) KR20230061405A (https=)
CN (1) CN116323632B (https=)
AU (1) AU2021325676A1 (https=)
CA (1) CA3190997A1 (https=)
ES (1) ES3061451T3 (https=)
IL (1) IL300441A (https=)
MX (1) MX2023001649A (https=)
PT (1) PT4192248T (https=)
WO (1) WO2022035752A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) * 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
AU643141B2 (en) 1991-03-15 1993-11-04 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US6664241B2 (en) * 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
JP6543272B2 (ja) * 2014-05-16 2019-07-10 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois 低減された毒性を有するアンホテリシンb誘導体
TWI702223B (zh) * 2014-06-12 2020-08-21 日商塩野義製藥股份有限公司 多烯巨環內酯衍生物
CA3021061C (en) * 2015-04-15 2023-10-24 Martin D. Burke Derivatives of amphotericin b
JP7477177B2 (ja) * 2018-09-07 2024-05-01 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 毒性が低減されたハイブリッドアムホテリシンb誘導体
EP4009985A4 (en) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B

Also Published As

Publication number Publication date
JP2023537921A (ja) 2023-09-06
EP4192248B1 (en) 2025-12-03
JP7656359B2 (ja) 2025-04-03
IL300441A (en) 2023-04-01
WO2022035752A1 (en) 2022-02-17
EP4696379A3 (en) 2026-02-25
EP4192248A1 (en) 2023-06-14
CA3190997A1 (en) 2022-02-17
CN116323632B (zh) 2024-12-31
EP4192248A4 (en) 2024-12-04
AU2021325676A1 (en) 2023-03-30
MX2023001649A (es) 2023-04-24
US20230357303A1 (en) 2023-11-09
KR20230061405A (ko) 2023-05-08
CN116323632A (zh) 2023-06-23
EP4696379A2 (en) 2026-02-18
PT4192248T (pt) 2026-02-11

Similar Documents

Publication Publication Date Title
ES2998396T3 (en) Substituted tetrahydrofurans as modulators of sodium channels
CO2022018811A2 (es) Inhibidores de la proteína kras g12c y usos de estos
CL2021001396A1 (es) Derivados de panteteína y usos de los mismos
ECSP088412A (es) Derivados de pirazina como moduladores de canal de sodio en el tratamiento del dolor
MX379530B (es) Compuestos agonistas del receptor muscarínico m4.
CR6881A (es) Derivados de pirazol
AR077252A1 (es) Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
UY31294A1 (es) Derivados de tetrahidrocarbozol, métodos para obtenerlos, formulaciones que los contienen y usos de los mismos
MX376743B (es) Síntesis de lactonas de ácido resorcílico útiles como agentes terapéuticos
DOP2024000209A (es) Compuestos de heteroarilo para el tratamiento del dolor
PA8548401A1 (es) Agentes antibacterianos
MX2024013019A (es) Compuestos de heteroarilo para el tratamiento del dolor
CL2022000319A1 (es) Derivados de amidas híbridas de anfotericina b
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
CO2022000749A2 (es) Inhibidores de monoacilglicerol lipasa (magl) heterocíclicos
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
CY1124346T1 (el) ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ
PE20240657A1 (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y sus usos medicos
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
BRPI0515991A (pt) derivados de bisariluréia substituìda heterocìclica como inibidores de cinase
MX2018010177A (es) Compuestos de 6,7-dihidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxa mida.
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
ES3061451T3 (en) Hybrid amide derivatives of amphotericin b
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
BR112019024804A2 (pt) compostos bicíclicos 5,6-fundidos e composições para o tratamento de doenças parasíticas